In HCC, increased CCR4 expression promotes the malignant proliferation of HCC and stimulates the migration and invasion of HCC through ERK/AKT/MMP2 signaling, so interfering with CCR4 may present an effective strategy for HCC treatment [129]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.